Oral Drug Delivery Resources

  1. Dosage Form Optimization For Patient-Centric Drug Development Process

    Designing products with patients in mind by utilizing superior formulation and drug delivery technologies in the early phases of development can minimize risks on the path to market.

  2. Formulation Research Strategy For Discovery- Stage New Drug Candidates 1/24/2022

    Early stage formulation studies, which should support the emerging target product profile, will often yield important experimental results to aid subsequent development of clinically relevant dosage forms.

  3. 5 Novel Techniques For Solubility Enhancement 2/28/2022

    Thanks to insoluble drug delivery technologies, the practice of reformulating poorly soluble drug products to improve efficacy, patient compliance and safety has now been widely adopted.

  4. Understanding Of Amorphous Solid Dispersions & Their Downstream Development 2/7/2022

    Understanding the properties of ASDs and their relationship to the downstream product scale up, stability, and in-vivo performance is critical to successfully utilize them for drug delivery of insoluble drugs.

  5. Strategies For Accelerating The Development Of Modified Release Oral Forms 3/3/2022

    Careful selection of appropriate excipients and delivery technologies is key to the design of modified release (MR) formulations fulfilling specific performance requirements.

  6. Improved Biomanufacturing Processes And Drug Product Stability 9/20/2022

    Improve upstream media for bioavailability and foam stability, downstream buffers for purification, and the formulation and final fill drug product stability with this highly interdisciplinary process.

  7. Overcoming Limitations To Achieve Uniform Dosing 1/24/2022

    An immediate need for lower dose capsules in the clinic posed several challenges in blend formulation with very tight timelines for delivery.

  8. Rational Design Of Oral Nanosuspensions For Insoluble Drugs 1/26/2022

    The advantages of nanosuspension dosage forms include improving bioavailability and API stability, increasing drug loading, better dose flexibility and accuracy, and easy swallowing for pediatric or geriatric populations.

  9. Combining Powdose® And Diffucaps® For Precise Solid Oral Dosing 6/30/2025

    Combining POWDOSE® and Diffucaps® enables precise, individualized solid oral dosing—improving drug delivery, patient compliance, and therapeutic outcomes in personalized medicine applications.

  10. Strategies For Optimal Scale-Up, Tech Transfer Of Oral Small Molecules

    Learn about the identification of CMAs, CPPs, and CQAs of drug products and how to predict their impact on formulation and manufacturing processes.